Anti-erectile Dysfunction (ED) Drugs Market size was valued at USD 4.5 Billion in 2024 and is projected to reach USD 7.2 Billion by 2033, exhibiting a CAGR of 5.5% from 2026 to 2033.
The South Korean anti-erectile dysfunction (ED) drugs market is experiencing significant growth, driven by an aging population and increasing awareness of ED treatments. In 2024, the market generated approximately USD 55.9 million in revenue and is projected to reach USD 101.9 million by 2030, reflecting a compound annual growth rate (CAGR) of 10.7% from 2025 to 2030.
Several key factors contribute to this expansion. The country's rapidly aging demographic has led to a higher prevalence of ED, necessitating effective pharmaceutical interventions. Additionally, societal openness towards discussing sexual health has improved, encouraging more individuals to seek medical assistance. The availability of various treatment options, including both brand-name and generic drugs, has also made ED medications more accessible to a broader segment of the population.
In terms of market segmentation, Viagra (sildenafil citrate) dominated the South Korean market in 2024, accounting for 62.79% of the revenue share. However, other drugs such as Cialis (tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), and mirodenafil are gaining traction. Notably, mirodenafil, developed by SK Chemicals Life Science, is marketed domestically under the trade name Mvix and is available in both tablet and orally dissolving film forms.
The South Korean pharmaceutical industry is subject to stringent regulations enforced by the Ministry of Food and Drug Safety (MFDS). Compliance with Good Manufacturing Practices (GMP) is mandatory, ensuring that products meet high safety and efficacy standards. These regulations are crucial for maintaining public trust and facilitating both domestic and international market access.
Recent trends indicate a surge in demand for ED medications, potentially influenced by economic factors. For instance, during economic downturns, there has been an unexpected increase in sales of ED drugs, suggesting a complex relationship between economic conditions and consumer behavior.
Manufacturers aiming to enter or expand within the South Korean anti-erectile dysfunction (ED) drugs market must navigate these regulatory landscapes and align with industry standards. This includes adhering to MFDS guidelines, ensuring GMP compliance, and staying attuned to market dynamics. Collaborations with local healthcare providers and continuous monitoring of consumer trends are also vital for successful market penetration and sustained growth.
Get an In-Depth Research Analysis of the South Korea Anti-erectile Dysfunction (ED) Drugs Market Size And Forecast [2025-2032]
Vivus
Inc.
Lilly ICOS LLC
Pfizer
Bayer
Hims
Menarini Group
Lupin
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
General Factory
CSBio
Dong-A ST
Metuchen Pharma
Seoul Pharma
Teva Pharma
S.K. Chemicals
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Anti-erectile Dysfunction (ED) Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Anti-erectile Dysfunction (ED) Drugs Market
Phosphodiesterase Type 5 Inhibitors (PDE5i)
Testosterone Replacement Therapy
Prostaglandin E1 (PGE1) Analogs
Other Drugs
Oral
Injectable
Topical
Subcutaneous
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Hospitals
Specialized Clinics
Homecare Settings
Inhibitors of Phosphodiesterase Type 5
Hormonal Therapy
Vasodilators
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Anti-erectile Dysfunction (ED) Drugs Market Research Analysis
1. Introduction of the South Korea Anti-erectile Dysfunction (ED) Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Anti-erectile Dysfunction (ED) Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Anti-erectile Dysfunction (ED) Drugs Market, By Type
6. South Korea Anti-erectile Dysfunction (ED) Drugs Market, By Application
7. South Korea Anti-erectile Dysfunction (ED) Drugs Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Anti-erectile Dysfunction (ED) Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/